Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR AI

Date Submitted: Dec 4, 2024
Open Peer Review Period: Dec 6, 2024 - Jan 31, 2025
Date Accepted: May 23, 2025
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Diagnostic and Screening AI Tools in Brazil’s Resource-Limited Settings: Systematic Review

Mancini L, Torres LEV, Coelho JAPdM, da Fonseca NB, Cordeiro PFD, Cavalcante SSN, Matos DDMdC

Diagnostic and Screening AI Tools in Brazil’s Resource-Limited Settings: Systematic Review

JMIR AI 2025;4:e69547

DOI: 10.2196/69547

PMID: 40929551

PMCID: 12422524

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Artificial Intelligence in Healthcare: Systematic Review of Diagnostic and Screening Tools in Brazil's Resource-Limited Settings

  • Leticia Mancini; 
  • Luiz Eduardo Vanderlei Torres; 
  • Jorge Artur Peçanha de Miranda Coelho; 
  • Nichollas Botelho da Fonseca; 
  • Pedro Fellipe Dantas Cordeiro; 
  • Samara Silva Noronha Cavalcante; 
  • Diego Dermeval Medeiros da Cunha Matos

ABSTRACT

Background:

Artificial Intelligence (AI) has the potential to transform global healthcare, with extensive application in Brazil, particularly for diagnosis (D) and screening (S).

Objective:

This study aimed to conduct a systematic review to understand AI applications in Brazilian healthcare, especially focusing on the resource-constrained environments.

Methods:

A systematic review was performed. The search strategy included the following databases: PubMed, Cochrane Library, Embase, Web of Science, LILACS, and SciELO. The search covered articles from 1993 to November 2023, with 25 articles selected for the final sample. Meta-analysis data were evaluated based on three main metrics: ROC curve, sensitivity, and specificity. A random effects model was applied for each metric to address study variability.

Results:

Key specialties for AI tools include ophthalmology and infectious disease, with a significant concentration of studies conducted in São Paulo state (52%). All articles included testing to evaluate and validate the tools; however, only two conducted secondary testing with a different population. In terms of risk of bias, 10 articles (40%) had medium risk, 8 articles (32%) had low risk, and 7 articles (28%) had high risk. Most studies were public initiatives, totaling 17 (68%), while 5 (20%) were private. In developing countries like Brazil, minimum technological requirements for implementing AI in healthcare must be carefully considered due to financial limitations and often insufficient technological infrastructure. Of the articles reviewed, 76% used computers, and 72% required the Windows operating system. The most used AI algorithm was Machine Learning (44%). The combined sensitivity was 0.8113, the combined specificity was 0.7417, and the combined area under the ROC curve (AUC) was 0.8308.

Conclusions:

There is a relative balance in the use of both diagnostic and screening tools, with widespread application across Brazil in varied contexts. The need for secondary testing highlights opportunities for future research.


 Citation

Please cite as:

Mancini L, Torres LEV, Coelho JAPdM, da Fonseca NB, Cordeiro PFD, Cavalcante SSN, Matos DDMdC

Diagnostic and Screening AI Tools in Brazil’s Resource-Limited Settings: Systematic Review

JMIR AI 2025;4:e69547

DOI: 10.2196/69547

PMID: 40929551

PMCID: 12422524

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.